XRCC1 and breast carcinoma: For instance, mutation R399Q was found to be positively associated to breast cancer, which is located at the end of the first BRCT domain of XRCC1 and at the interface of the best binding mode predicted by Cluspro in the ETS(Ets-1)/BRCT(XRCC1) docking run (Figure 6).